Ludwigshafen, Germany

Bernhard K Muller

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernhard K Muller. Retrieved from https://idiyas.com/inventor/bernhard-k-muller-75kkzap3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Sure! Here is the article about inventor Bernhard K Muller:

Title: Unveiling the Innovations of Bernhard K Muller in Ludwigshafen, DE

Introduction:

Bernhard K Muller, a distinguished inventor based in Ludwigshafen, DE, has made significant contributions to the field of pharmaceuticals with his groundbreaking patent on 4-(4-pyridinyl)-benzamides as rock activity modulators. His work revolves around developing novel compounds with therapeutic properties aimed at treating diseases responsive to Rho kinases (ROCKs) modulation.

Latest Patents:

Bernhard K Muller holds one patent for the invention of 4-(4-pyridinyl)-benzamides and their potential applications as rock activity modulators. The compounds outlined in his patent have shown promising results in the treatment of various illnesses, showcasing his innovative approach in the pharmaceutical sector.

Career Highlights:

Currently affiliated with AbbVie Inc., Bernhard K Muller brings his expertise to the forefront in creating groundbreaking solutions in the pharmaceutical industry. His dedication to research and development has led to the fruition of pioneering patents that have the potential to revolutionize the healthcare landscape.

Collaborations:

In his professional journey, Bernhard K Muller has collaborated with esteemed colleagues such as Helmut Mack and Nicole Teusch. Together, they have worked towards pushing the boundaries of innovation in pharmaceuticals, fostering a collaborative environment that fosters creativity and scientific advancement.

Conclusion:

Bernhard K Muller stands as a beacon of innovation in the field of pharmaceuticals, with his inventive solutions paving the way for enhanced therapeutic interventions. His patent on 4-(4-pyridinyl)-benzamides serves as a testament to his commitment to driving positive change in healthcare, leaving a lasting impact on the industry and potentially improving patient outcomes worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…